Code | 88300 | ||||||||||
MA number | 10/0173/85-CS | ||||||||||
Product Form: | sus por 1x20 ml/400 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
Therapeutic Class: | 10 - ANTHELMINTICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | bottle HDPE | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 30.07.1985 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: | SPC_ZENTEL_sus por_02_2022.pdf |
PIL: | PIL_ZENTEL sus por_02_2022.pdf |
Safety feature | Yes |
Data update: | 16.02.2022 |